Treatment Patterns and Outcomes Among Patients Who Initiate Therapy for Relapsed/Refractory Multiple Myeloma (RRMM) in Routine Care

被引：0
|
作者：
Romanus, Dorothy [1 ]
Jhaveri, Mehul [1 ]
Labotka, Richard [1 ]
Henk, Henry [2 ]
Seal, Brian [1 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Optum, HEOR, Eden Prairie, MN USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
  • [2] Patient Characteristics, Treatment Patterns and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients in Japan
    Jun, Gyungjin
    Luptakova, Katarina
    Koizumi, Hiroo
    Iwasaki, Kosuke
    Hiroi, Shinzo
    Soeda, Junpei
    [J]. BLOOD, 2016, 128 (22)
  • [3] Predictors of Second-Line Treatment Choice with Triplet Therapy in Routine Care Among Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Romanus, Dorothy
    Jhaveri, Mehul
    Labotka, Richard
    Henk, Henry
    Seal, Brian
    [J]. BLOOD, 2015, 126 (23)
  • [4] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [5] PRACTICE PATTERNS AND OUTCOMES IN ELDERLY US PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Romanus, D.
    Raju, A.
    Yong, C.
    Seal, B.
    Farrelly, E.
    Labotka, R.
    Jhaveri, M.
    Noga, S.
    Blazer, M.
    Parameswaran, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 532 - 533
  • [6] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [7] Real-World Treatment Patterns, Health Care Utilization, and Costs Among Relapsed/Refractory Multiple Myeloma (rrMM) Patients
    Shao, Changxia
    Monberg, Matthew
    Cao, Xiting
    Zhou, Wei
    Zhong, Yichen
    Marinello, Patricia
    [J]. BLOOD, 2016, 128 (22)
  • [8] Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Secondand Third-Line Therapy in a Medicare Population
    Tkacz, Joseph
    Gorsh, Boris
    Molinari, Alexa
    Boytsov, Natalie
    Wang, Peter Feng
    Perera, Sue
    Landi, Suzanne
    Hanna, Maya
    Johnson, William
    Schroeder, Amy
    Paka, Prani
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S423 - S423
  • [9] Treatment Patterns in Patients (pts) with Refractory/Relapsed Multiple Myeloma (RRMM) in Germany between 2016 and 2018
    Merz, Maximilian
    Patel, Vishal
    Kutikova, Lucie
    Lebioda, Andrea
    Schoehl, Martina
    Kellermann, Lenka
    Goldschmidt, Hartmut
    [J]. BLOOD, 2019, 134
  • [10] Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    DerSarkissian, Maral
    Duh, Mei Sheng
    Lafeuille, Marie-Helene
    Posner, George
    Ralston, Stephen
    Zagadailov, Erin
    Ba-Mancini, Abbie
    Rifkin, Robert M.
    [J]. BLOOD, 2017, 130
12345